A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol A
Completed · Phase 3 · Has a placebo group
Conditions studied: Macular Telangiectasia Type 2 (MacTel)
In brief
This study is a phase 3, randomized, multi-center study to evaluate the efficacy and safety of the NT-501 implants in participants with macular telangiectasia type 2.
Key facts
- Study ID
- NCT03316300
- Run by
- Neurotech Pharmaceuticals
- People needed
- 120
- Starts
- 2017-11-24
- Expected to finish
- 2022-09-23
- Last updated by the study team
- 2024-09-24
Who can join
Age: 21 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Scripps Clinic Medical Group — La Jolla, California, United States
- Jules Stein Eye Institute / David Geffen School of Medicine — Los Angeles, California, United States
- Byers Eye Institute at Stanford University — Palo Alto, California, United States
- Bay Area Retina Associates — Walnut Creek, California, United States
- Retina Consultants of Southern Colorado, P.C. — Colorado Springs, Colorado, United States
- Retina Associates of New Orleans — Metairie, Louisiana, United States
- National Institute of Health, NIH — Bethesda, Maryland, United States
- Cumberland Valley Retina Consultants — Hagerstown, Maryland, United States
- Associated Retinal Consultants, P.C. — Royal Oak, Michigan, United States
- Sierra Eye Associates — Reno, Nevada, United States
- Retina Associates of Cleveland, Inc. — Cleveland, Ohio, United States
- Tulsa Retina Consultants — Tulsa, Oklahoma, United States
- Retina Northwest, PC — Portland, Oregon, United States
- Southeastern Retina Associates, PC — Knoxville, Tennessee, United States
- Texas Retina Associates — Dallas, Texas, United States
- University of Utah John A. Moran Eye Center — Salt Lake City, Utah, United States
- Lions Eye Institute — Perth, Western Australia, Australia
- Lariboisiere Hospital — Paris, France
- Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust — Oxford, Oxfordshire, United Kingdom
- Moorfields Eye Hospital NHS Foundation Trust — London, United Kingdom
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.